List of Tables
Table 1. Anti-epileptic Drugs for Pediatrics Market Trends
Table 2. Anti-epileptic Drugs for Pediatrics Market Drivers & Opportunity
Table 3. Anti-epileptic Drugs for Pediatrics Market Challenges
Table 4. Anti-epileptic Drugs for Pediatrics Market Restraints
Table 5. Global Anti-epileptic Drugs for Pediatrics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Company (2019-2024)
Table 7. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anti-epileptic Drugs for Pediatrics Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Anti-epileptic Drugs for Pediatrics Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anti-epileptic Drugs for Pediatrics Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-epileptic Drugs for Pediatrics
Table 13. Global Anti-epileptic Drugs for Pediatrics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-epileptic Drugs for Pediatrics as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-epileptic Drugs for Pediatrics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anti-epileptic Drugs for Pediatrics Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anti-epileptic Drugs for Pediatrics Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anti-epileptic Drugs for Pediatrics Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Anti-epileptic Drugs for Pediatrics Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Anti-epileptic Drugs for Pediatrics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti-epileptic Drugs for Pediatrics Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-epileptic Drugs for Pediatrics Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anti-epileptic Drugs for Pediatrics Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Anti-epileptic Drugs for Pediatrics Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Anti-epileptic Drugs for Pediatrics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anti-epileptic Drugs for Pediatrics Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anti-epileptic Drugs for Pediatrics Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anti-epileptic Drugs for Pediatrics Sales Value by Region (2019-2024) & (%)
Table 44. Global Anti-epileptic Drugs for Pediatrics Sales Value by Region (2025-2030) & (%)
Table 45. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anti-epileptic Drugs for Pediatrics Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Anti-epileptic Drugs for Pediatrics Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Volume, (2025-2030) & (K Units)
Table 57. Mylan N.V Company Information
Table 58. Mylan N.V Introduction and Business Overview
Table 59. Mylan N.V Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Mylan N.V Anti-epileptic Drugs for Pediatrics Product Offerings
Table 61. Mylan N.V Recent Development
Table 62. Cephalon, Inc Company Information
Table 63. Cephalon, Inc Introduction and Business Overview
Table 64. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 66. Cephalon, Inc Recent Development
Table 67. GlaxoSmithKline plc Company Information
Table 68. GlaxoSmithKline plc Introduction and Business Overview
Table 69. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 71. GlaxoSmithKline plc Recent Development
Table 72. Janssen Pharmaceuticals Company Information
Table 73. Janssen Pharmaceuticals Introduction and Business Overview
Table 74. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product Offerings
Table 76. Janssen Pharmaceuticals Recent Development
Table 77. Novartis AG Company Information
Table 78. Novartis AG Introduction and Business Overview
Table 79. Novartis AG Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Novartis AG Anti-epileptic Drugs for Pediatrics Product Offerings
Table 81. Novartis AG Recent Development
Table 82. Pfizer, Inc Company Information
Table 83. Pfizer, Inc Introduction and Business Overview
Table 84. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 86. Pfizer, Inc Recent Development
Table 87. Sanofi S.A Company Information
Table 88. Sanofi S.A Introduction and Business Overview
Table 89. Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Sanofi S.A Anti-epileptic Drugs for Pediatrics Product Offerings
Table 91. Sanofi S.A Recent Development
Table 92. UCB Pharma Limited Company Information
Table 93. UCB Pharma Limited Introduction and Business Overview
Table 94. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product Offerings
Table 96. UCB Pharma Limited Recent Development
Table 97. Sunovion Pharmaceuticals Limited Company Information
Table 98. Sunovion Pharmaceuticals Limited Introduction and Business Overview
Table 99. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product Offerings
Table 101. Sunovion Pharmaceuticals Limited Recent Development
Table 102. Valeant Pharmaceuticals International, Inc Company Information
Table 103. Valeant Pharmaceuticals International, Inc Introduction and Business Overview
Table 104. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product Offerings
Table 106. Valeant Pharmaceuticals International, Inc Recent Development
Table 107. Zogenix Company Information
Table 108. Zogenix Introduction and Business Overview
Table 109. Zogenix Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Zogenix Anti-epileptic Drugs for Pediatrics Product Offerings
Table 111. Zogenix Recent Development
Table 112. GW Pharmaceuticals Company Information
Table 113. GW Pharmaceuticals Introduction and Business Overview
Table 114. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product Offerings
Table 116. GW Pharmaceuticals Recent Development
Table 117. Insys Company Information
Table 118. Insys Introduction and Business Overview
Table 119. Insys Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Insys Anti-epileptic Drugs for Pediatrics Product Offerings
Table 121. Insys Recent Development
Table 122. Zynerba Company Information
Table 123. Zynerba Introduction and Business Overview
Table 124. Zynerba Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Zynerba Anti-epileptic Drugs for Pediatrics Product Offerings
Table 126. Zynerba Recent Development
Table 127. Bausch Health Companies Inc. Company Information
Table 128. Bausch Health Companies Inc. Introduction and Business Overview
Table 129. Bausch Health Companies Inc. Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Bausch Health Companies Inc. Anti-epileptic Drugs for Pediatrics Product Offerings
Table 131. Bausch Health Companies Inc. Recent Development
Table 132. Johnson & Johnson Service Company Information
Table 133. Johnson & Johnson Service Introduction and Business Overview
Table 134. Johnson & Johnson Service Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Johnson & Johnson Service Anti-epileptic Drugs for Pediatrics Product Offerings
Table 136. Johnson & Johnson Service Recent Development
Table 137. Teva Pharmaceutical Industries Ltd. Company Information
Table 138. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 139. Teva Pharmaceutical Industries Ltd. Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Teva Pharmaceutical Industries Ltd. Anti-epileptic Drugs for Pediatrics Product Offerings
Table 141. Teva Pharmaceutical Industries Ltd. Recent Development
Table 142. Sumitomo Dainippon Pharma Co., Ltd. Company Information
Table 143. Sumitomo Dainippon Pharma Co., Ltd. Introduction and Business Overview
Table 144. Sumitomo Dainippon Pharma Co., Ltd. Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Sumitomo Dainippon Pharma Co., Ltd. Anti-epileptic Drugs for Pediatrics Product Offerings
Table 146. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Anti-epileptic Drugs for Pediatrics Downstream Customers
Table 150. Anti-epileptic Drugs for Pediatrics Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-epileptic Drugs for Pediatrics Product Picture
Figure 2. Global Anti-epileptic Drugs for Pediatrics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anti-epileptic Drugs for Pediatrics Sales Volume (2019-2030) & (K Units)
Figure 5. Global Anti-epileptic Drugs for Pediatrics Sales Price (2019-2030) & (USD/Unit)
Figure 6. Anti-epileptic Drugs for Pediatrics Report Years Considered
Figure 7. Global Anti-epileptic Drugs for Pediatrics Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anti-epileptic Drugs for Pediatrics Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-epileptic Drugs for Pediatrics Revenue in 2023
Figure 10. Anti-epileptic Drugs for Pediatrics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 1st Generation Picture
Figure 12. 2nd Generation Picture
Figure 13. 3rd Generation Picture
Figure 14. Global Anti-epileptic Drugs for Pediatrics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Anti-epileptic Drugs for Pediatrics Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Anti-epileptic Drugs for Pediatrics Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Retail Pharmacies
Figure 21. Product Picture of Online Pharmacies
Figure 22. Global Anti-epileptic Drugs for Pediatrics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Anti-epileptic Drugs for Pediatrics Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Anti-epileptic Drugs for Pediatrics Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Anti-epileptic Drugs for Pediatrics Price by Application (2019-2030) & (USD/Unit)
Figure 27. North America Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Anti-epileptic Drugs for Pediatrics Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Anti-epileptic Drugs for Pediatrics Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-epileptic Drugs for Pediatrics Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Anti-epileptic Drugs for Pediatrics Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Anti-epileptic Drugs for Pediatrics Sales Volume (%), (2019-2030)
Figure 39. United States Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 45. China Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 47. China Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 57. India Anti-epileptic Drugs for Pediatrics Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Anti-epileptic Drugs for Pediatrics Sales Value by Type (%), 2023 VS 2030
Figure 59. India Anti-epileptic Drugs for Pediatrics Sales Value by Application (%), 2023 VS 2030
Figure 60. Anti-epileptic Drugs for Pediatrics Industrial Chain
Figure 61. Anti-epileptic Drugs for Pediatrics Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
